BioCentury
ARTICLE | Company News

Noven, Novartis deal

November 13, 2000 8:00 AM UTC

NOVN granted NVS exclusive rights to market Estradot transdermal 17-beta estradiol in countries outside the U.S., Canada and Japan to treat postmenopausal and perimenopausal symptoms and to prevent p...